The Daily Biotech Pulse: Neurocrine’s Parkinson’s Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven’s Migraine Drug – Benzinga

The Daily Biotech Pulse: Neurocrine’s Parkinson’s Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven’s Migraine Drug – Benzinga
The Daily Biotech Pulse: Neurocrine's Parkinson's Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven's Migraine Drug  BenzingaHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July ... read more
Source: Google NewsPublished on 2019-07-11